Crescita Therapeutics (CTX) News Today C$0.46 +0.01 (+1.10%) As of 08/27/2025 11:13 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Crescita Reports Second Quarter 2025 ResultsAugust 6, 2025 | financialpost.comFCrescita Therapeutics Inc. (CTX.TO) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comCrescita Therapeutics First Quarter 2025 Earnings: CA$0.049 loss per share (vs CA$0.032 loss in 1Q 2024)May 16, 2025 | finance.yahoo.comCrescita Reports First Quarter 2025 ResultsMay 14, 2025 | financialpost.comFCrescita Reports First Quarter 2025 ResultsMay 14, 2025 | financialpost.comFInsider Buying: Crescita Therapeutics Inc. (TSE:CTX) Director Buys 86,000 Shares of StockDecember 29, 2024 | insidertrades.comCrescita Therapeutics Inc. (CRRTF)November 24, 2024 | finance.yahoo.comChordia Therapeutics Advances Cancer Drug DevelopmentNovember 20, 2024 | markets.businessinsider.comPromising Phase 1 Results of Compass Therapeutics’ CTX-471 Highlight Potential for Advanced Solid Tumors TreatmentNovember 11, 2024 | markets.businessinsider.comCompass Therapeutics presents biomarker data related to CTX-471November 8, 2024 | markets.businessinsider.comCrescita Therapeutics Announces Approval of Normal Course Issuer BidSeptember 24, 2024 | businesswire.comCrescita Therapeutics Inc. Reports Second Quarter 2024 ResultsAugust 7, 2024 | finanznachrichten.deCrescita Reports Second Quarter 2024 ResultsAugust 7, 2024 | financialpost.comFBuy Rating Affirmed on Compass Therapeutics as Clinical Trials of CTX-009 Show Promise in Biliary Tract Cancer TreatmentAugust 6, 2024 | markets.businessinsider.comClosing Bell: Crescita Therapeutics Inc up on Monday (CTX)July 31, 2024 | theglobeandmail.comCrescita secures four-year term contract manufacturing revenue from largest CMO clientJuly 22, 2024 | msn.comCrescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 YearsJuly 22, 2024 | finance.yahoo.comLeading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year AgreementJuly 19, 2024 | finance.yahoo.comCrescita Reports First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comCTNM Contineum Therapeutics, Inc.April 18, 2024 | seekingalpha.comCrescita Reports Q4 and Fiscal 2023 ResultsMarch 13, 2024 | finance.yahoo.comCrescita Therapeutics Inc CTXFebruary 16, 2024 | morningstar.comMClosing Bell: Crescita Therapeutics Inc up on Wednesday (CTX)December 13, 2023 | theglobeandmail.comCrescita Reports Third Quarter 2023 ResultsNovember 8, 2023 | finance.yahoo.comClosing Bell: Crescita Therapeutics Inc up on Thursday (CTX)November 4, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Friday (CTX)September 29, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Tuesday (CTX)September 1, 2023 | theglobeandmail.comCrescita Reports Second Quarter 2023 ResultsAugust 9, 2023 | finance.yahoo.comClosing Bell: Crescita Therapeutics Inc flat on Monday (CTX)August 6, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Friday (CTX)July 29, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Monday (CTX)July 18, 2023 | theglobeandmail.comSubdued Growth No Barrier To Crescita Therapeutics Inc.'s (TSE:CTX) PriceJune 8, 2023 | finance.yahoo.comCroma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeJune 1, 2023 | finance.yahoo.comCrescita Reports First Quarter 2023 ResultsMay 11, 2023 | finance.yahoo.comClosing Bell: Crescita Therapeutics Inc flat on Friday (CTX)April 15, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Tuesday (CTX)April 12, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Thursday (CTX)April 11, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Wednesday (CTX)April 8, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Wednesday (CTX)April 6, 2023 | theglobeandmail.comCrescita Therapeutics GAAP EPS of C$0.06, revenue of C$6MMarch 17, 2023 | seekingalpha.comCrescita Therapeutics Inc. Reports Q4 and Fiscal 2022 ResultsMarch 15, 2023 | finanznachrichten.deCrescita Therapeutics GAAP EPS of $0.06, revenue of $6MMarch 15, 2023 | msn.comCrescita Therapeutics Q4 Profit Rises, But Revenues DeclineMarch 15, 2023 | markets.businessinsider.comCrescita Reports Q4 and Fiscal 2022 ResultsMarch 15, 2023 | finance.yahoo.comCTX:CA Crescita Therapeutics Inc.November 16, 2022 | seekingalpha.comCrescita Therapeutics Third Quarter 2022 Earnings: EPS: CA$0.009 (vs CA$0.043 loss in 3Q 2021)November 11, 2022 | finance.yahoo.comCrescita Reports Third Quarter 2022 ResultsNovember 9, 2022 | finance.yahoo.comCrescita Therapeutics GAAP EPS of C$0.00, revenue of C$6.51MAugust 12, 2022 | seekingalpha.comCrescita Therapeutics IncAugust 10, 2022 | reuters.comCrescita Reports Second Quarter 2022 ResultsAugust 10, 2022 | finance.yahoo.com Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTX Media Mentions By Week CTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTX News Sentiment▼0.000.99▲Average Medical News Sentiment CTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTX Articles This Week▼00▲CTX Articles Average Week Get the Latest News and Ratings for CTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Crescita Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LABS News VM News WLLW News CWEB News VPH News DHT.UN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CTX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access